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In Vivo Heteronuclear Magnetic Resonance Spectroscopy
Blanca Lizarbe, Antoine Cherix, and Rolf Gruetter
Abstract
Magnetic Resonance Spectroscopy is a technique that has the capability of measuring metabolites in vivo
and, in appropriate conditions, to infer its metabolic rates. The success of MRS depends a lot on its
sensitivity, which limits the usage of X-nuclei MRS. However, technological developments and refinements
in methods have made in vivo heteronuclear MRS possible in humans and in small animals. This chapter
provides detailed descriptions of the main procedures needed to perform successful in vivo heteronuclear
MRS experiments, with a particular focus on experimental setup in 13C MRS experiments in rodents.
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1 Introduction
Heteronuclear Magnetic Resonance Spectroscopy (MRS) is based
in the detection of nuclear magnetic resonances (NMR) from
nuclei other than protons. In preclinical research, applications rely
on the ability of MRS to noninvasively measure metabolites inside
living organs, assessing the content of nuclei like 13C, 15N, 17O,
19F, and 31P. One of the most common applications in hetero-
nuclear MRS is in vivo 13C spectroscopy, which can be used to
determine rates of neurotransmission and neuroenergetics
[1]. Notably, 17O and 31P measurements can determine cerebral
metabolic rates of oxygen and ATP inside the mitochondria [2] and
its usage is quite extended in preclinical MRS. Nonetheless, in vivo
MRS of X-nuclei is challenging due to the low sensitivity detection
of the non-proton nuclei; they have a substantially lower gyromag-
netic ratio and typically lower natural abundance than the 1H
nucleus. Consequently, technical demands for its detection are
very high, and, currently, in vivo heteronuclear MRS in humans is
limited to a number of research groups in the world. In the past two
decades, however, sensitivity and spectral resolution of MRS data
has been enhanced by implementation of scanners with higher
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magnetic field strength, as well as improved radio-frequency coil
designs, better radio-frequency pulse sequences, and more precise
methods for localized shimming. Therefore, X-nuclei MRS techni-
ques are becoming more and more accessible, and, especially in
preclinical investigations, further studies have been published in the
last years. Non-proton detection techniques, however, are—even in
animal MRS—still hampered by lower sensitivity detection. Thus,
implementation of a precise methodology is needed to guarantee
accurate and reproducible results. On these grounds, the aim of this
book chapter is to detail the procedures that are routinely imple-
mented in preclinical in vivo heteronuclear MRS experiments. For
the sake of completeness, protocols will be described first in a more
general way—in terms of the nuclei investigated or substrate used—
and, second, and more specifically, examples for 13C detection after
labeled glucose infusion in rodents will be given. Hence, the first
part of this chapter is dedicated to give a general description of
basics of heteronuclear NMR signal and hardware requirements;
the second part provides a concise description of the materials used
and the third part elaborates the description of the methodologies.
Finally, an additional section calledNotes includes extra information





Nuclear magnetic resonance spectroscopy is based, among other
things, in detecting the resonances of the nuclei with non-zero spin
(I 6¼ 0) after the application of a constant magnetic field and a
radiofrequency pulse. The most commonly studied nuclei are 1H,
31P, and 13C, although nuclei from isotopes of many other elements
(e.g., 2H, 6Li, 10B, 11B, 14N, 15N, 17O, 19F, 23Na, 29Si, 35Cl, 113Cd,
129Xe, 195Pt) have been used in high-field NMR spectroscopy
[3]. Overall, the frequency at which a specific nucleus resonates
depends on the external magnetic field strength applied, the gyro-
magnetic ratio of the nucleus, and its chemical environment. Par-
ticularly, the dependence on the chemical milieu has its origin in
two different phenomena: the shielding of the magnetic field by the
surrounding electrons, on one hand, and the interactions between
nuclei in the same molecule, on the other. Notably, interaction
between nuclear spins is not limited to nuclei of the same type—
the so-called homonuclear coupling—but also between different
types—the heteronuclear coupling. This interaction between differ-
ent nuclei results in a splitting of resonances into several smaller
lines at different frequencies [3], and all atoms that have I 6¼ 0 are
subjected to it accordingly to the chemical structure of the mole-
cule. The splitting of the resonances complicates the understanding
of the spectra, not only due to the incorporation of the additional
lines but also for the decrease in signal intensity of the original (and
not coupled) signal. In the study of 1HNMR signals, heteronuclear
coupling is normally neglected because, even though most protons
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are bond to carbon molecules (at least in organic compounds), the
natural abundance of 13C is only around 1.1%, which almost elim-
inates the potential coupling effects. In non-proton detection MRS
experiments, however, heteronuclear coupling becomes critical
because the X-nuclei investigated are often bonded to the
NMR-visible H atoms, making proton decoupling mandatory—
and sometimes technically very challenging [4]—to obtain spectra
with enough signal intensities.
There are two main techniques detecting non-proton nuclei by
MRS: direct detection and indirect detection [4]. The principal
characteristics that define—and distinguish—both methods are
increased spectral dispersion of the resonances from the metabolites
for the first one, and higher sensitivity for the second one. Conse-
quently, depending on the type of study that is to be performed,
one of the methods can be chosen. For MRS in small volumes, for
example, indirect methods with higher sensitivity might be more
appropriate. If a higher separation between resonances is required,
then a direct detection approach should be chosen.
Direct detection methods measure the NMR signal of the
X-nuclei. Excitation through RF pulses is performed at the
frequency of the X-nuclei investigated, where the resonances
are also received, and decoupling is performed in the 1H chan-
nel. This has two immediate consequences: larger chemical shift
dispersion (~30 ppm for 31P NMR and >200 ppm for 13C
NMR) and substantial loss of sensitivity. Indeed, decreased sen-
sitivity is a consequence of either the lower natural abundance
(1.1% for 13C) and/or low gyromagnetic ratio
γ13C=γ1H ¼ 0:251; γ31P=γ1H ¼ 0:405ð Þ. Nevertheless, this low sensi-
tivity can be overcome by the implementation of optimized
methodologies, such as the exogenous administration of labeled
precursors—mandatory for isotopes with low natural abun-
dance—, polarization transfer techniques [5], or methods taking
advantage of the Nuclear Overhauser Effect (NOE) [6]. Sensitiv-
ity enhancement by polarization transfer is achieved by transfer-
ring the nuclear spin polarization of protons to the X-nucleus
through chemical bonds, while NOE transfers the polarization
via cross-relaxation. Figure 1 shows a scheme of the original
distortionless enhancement by polarization transfer (DEPT)
sequence [5] (top), and a more developed version (bottom)
implemented by Henry P.G. et al. [7]. In this scheme, localiza-
tion is performed on the 1H magnetization and the localized
magnetization is subsequently transferred to carbon. This avoids
potential chemical shift displacement errors induced by the large
chemical shift displacement of metabolites in the 13C spectra.
Another way to improve sensitivity in direct detection methods
is to use hyperpolarization [8]. Hyperpolarized 13C MRS has
the potential to increase the sensitivity by several orders of magni-
tude by using a nonequilibrium polarization [9]. Particularly,
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hyperpolarized 13CMRS, due to the many technological challenges
related to the generation and preservation of nonequilibrium polar-
ization, is commonly limited to the detection of fast and dynamic
metabolic pathways.
In indirect detection methods, like 1H-[13C], the measured
signal arises from the protons that are bond to 13C. In this case,
the signal is transmitted and received through the 1H channel and
decoupling is performed at the X-nucleus frequency. The main
advantage of this approach is that the larger gyromagnetic ratio of
protons and its increased natural abundance leads to a significantly
higher sensitivity. In fact, the sensitivity detection has been recently
shown to be high enough to perform in vivo MRS experiments in
the mouse brain [10], or even in small areas of it [11]. Generally,
1H-[13C] methods can be divided into single-shot multiple-quan-
tum coherences-based procedures (MQC) [12] and J-difference-
based methods [13]. The MQC-based methods selectively detect
the 1H NMR signals attached to 13C nuclei by destroying, though
dephasing, all other 1H coherences. However, the removal of all
these other 1H NMR signals prevents the calculation of 13C frac-
tional enrichments (FE) and the monitoring of metabolite levels
without 13C label incorporation. J-difference methods, on the
other hand, use the different evolution (refocusing) of the magne-
tization of the protons that are coupled to 13C atoms, compared to
Fig. 1 1H localized broadband 13C NMR spectroscopy of the rat brain in vivo at 9.4 T. (a) the original DEPT
sequence; (b) modified sequence. The 13C part of DEPT is replaced by a segmented adiabatic 0 BIR-4 pulse.
Dephasing gradients (1 ms duration, 46 mT/m) are added between the RF pulses in DEPT to eliminate
unwanted, offset-dependent coherences. The flip angle of last 1H pulse is set to a nominal 45 to detect
signals simultaneously from the CH, CH2, and CH3 groups
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the refocusing magnetization of non-coupled protons, to
detect both the total (12C þ 13C) content and the 13C fraction.
Figure 2 depicts a scheme of the SPECIAL-BISEP sequence [14]
that has been recently implemented in preclinical scanners and that




The performance of successful heteronuclear MRS experiments
in vivo can depend on the technical requirements of the methodol-
ogy. Notably, because poor sensitivity is one of the main technical
issues, non-protonMRS is favored by the use of high field scanners,
where the signal to noise ratio (SNR) is increased with the square
root of the magnetic field B0. Naturally, at high magnetic fields, the
frequency separation between metabolites is also improved, result-
ing in a largely increased number of detectable metabolites at high
spatial specificity. However, high fields typically are associated with
increased technical challenges, such as inhomogeneous transmit
(B1) fields, an increased impact of microscopic and macroscopic
susceptibility differences on static B0 inhomogeneity, shortened T2
and lengthened T1 relaxation times and a lower effective B1 field
strength. Nonetheless, several studies demonstrate that the
improvements achieved with the high field can largely overcome
the technical challenges, extending the number of quantifiable
metabolites and increasing spatial resolution and specificity
[15–17]. Other limiting factors of heteronuclear MRS experiments
Fig. 2 (a) Sequence diagram of SPECIAL-BISEP (TE ¼ 2.8 ms). The editing is achieved by applying an AFP in
the 13C channel on alternate scans; (b) in vitro validation of the editing scheme performed at 14.1 T on a
solution of 67% enriched [2-13C]sodium acetate (no 13C decoupling during the acquisition is applied). When
the 13C AFP is turned off, the inversion BISEP pulse acts as a 0 BIR-4 pulse (top), while when AFP is turned on,
13C-coupled 1H resonances are inverted (middle). In the difference spectrum (bottom), the uncoupled
resonances (1H-[2-12C]) are minimized and only the 13C-coupled 1H resonances (1H-[2-13C]) are detected
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are the need of designing specific RF coils, implementation of addi-
tional RF channels, application of decoupling schemes and adiabatic
pulses. Each of these requirements will be briefly described in the
following paragraphs.
1.2.1 Design of Specific
RF Coils
RF coils are frequency-dependent, and a coil that is to be used
during heteronuclear NMR studies should consist of several
loops, each one corresponding to the different nuclei to be inves-
tigated. Moreover, the RF coil should be designed in a way that the
respective RF fields of the different loops are electrically isolated
[18]. A more detailed description of the characteristics of the RF




Heteronuclear MRS experiments are only possible in spectrometers
equipped with at least an additional RF broadband channel. Fur-
thermore, acquisition has to be done in the two channels concomi-
tantly, either during the application of decoupling schemes—
proton or X-nuclei decoupling for direct or indirect detection,
respectively—or during the application of inversion pulses or dur-
ing polarization transfer sequences [4].
2 Materials
In the following paragraphs, a list including the main materials used
during a typical in vivo MRS experiment is provided.
1. Coil. Standard design for RF coil for 13C direct and indirect
detection is generally as follows: two proton transmit/receive
surface coils in quadrature lying on top of a single carbon coil
[19]. However, in order to increase proton sensitivity for 1H-
[13C] spectroscopy, an alternative has been proposed by put-
ting the proton loops on the bottom, in order to be closer to
the sample [20].
2. External reference. Typically, a glass sphere containing 13C
labeled formic acid (FA) can be at the center of the coil. This
allows measuring the 13C FA resonance in the magnet to set the
offset for the RF pulses in the carbon channel. Furthermore,
the reference allows to measure the power performance of the
coil and to adjust the power for efficient 90 and 180 pulses in
both proton and carbon channels. Briefly, to adjust the power
values on the different channel the process is as follows: first, an
experiment with a phantom is performed, and power value of a
180 hard pulse in the FA sphere is measured. Secondly, the
same pulse is performed in vivo in the FA. If values in the FA
change, values in the sample should change concomitantly.
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3. 13C labeled substrates. Glucose is the most common substrate
that allows investigating both oxidative and glycolytic metabo-
lism; however, other substrates have been used to target specific
metabolic pathways. Notably, acetate can be used to measure
specifically astrocytic oxidative metabolism [21], whereas lac-
tate can be used for investigating neuronal oxidative metabo-
lism [22]. Besides the differences in cost, the different 13C-
labeled glucose substrates can be used for different purpose. It
is thus primordial to choose the appropriate substrate accord-
ing to the technique (mainly direct and indirect 13C MRS) and
the need for an increased signal relative to cost. After glycolysis,
carbon positions 1 and 6 of glucose will label the methyl group
of pyruvate, leading primarily to the labeling of glutamate C4
following the pyruvate dehydrogenase pathway and glutamate
C2 for the pyruvate carboxylase pathway [23]. [1, 6-13C]
glucose is thus twice as efficient as [1-13C] glucose labeling,
and thus detecting, TCA cycle aminoacids. The use of [1,
6-13C] glucose is particularly important for 13C direct detec-
tion, in order to avoid splitting of peaks due to coupling
between adjacent 13C carbons. Because of this coupling,
[U-13C] glucose should best used in 1H-[13C] MRS, where
decoupling in the carbon channel allows to eliminate reso-
nances from heteronuclear coupling. [2-13C] glucose can be
used to investigate the anaplerotic metabolism of glial cells as it
will label specifically glutamine positions C2 and C3 due to the
presence of pyruvate carboxylase [24].
4. Infusion pump. Infusion can be done with a pump suitable for
infusion from any syringe and operating in both infusion and
withdrawal mode. The syringe containing the labeled glucose
solution is connected to a polyethylene line that has to be long
enough to cover the distance between the catheter and the
pump, i.e., the distance between the animal in the magnet
and the operator in the monitoring room. Adding a transparent
tube connector at the end of the line can help for controlling
the adjunction of the 99% enriched 13C glucose bolus solution.
5. Physiology monitoring. Temperature of the animal can be con-
trolled with a water circulating system covering the animal and
controllable in the preparation room. Respiration and temper-
ature can be monitored with a module located near the animal
in the magnet bore and a control/gating module connected to
a computer located near the operator console module. Glucose
can be measured with a single drop of blood using any com-
mercial system. Small volume sampling is critical for small
animals with small blood volumes such as mice or for repeated
measurements.
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6. Anesthesia. Animal should be anesthetized in an induction
chamber with 3–4% isoflurane delivered by an isoflurane vapor-
izer. Chamber should be connected with a gas outlet system
linked to a scavenge system for isoflurane elimination. Vapor-
izer should be connected to both air and oxygen for a better
control of animal oxygenation. The use of α-chloralose should
be only limited to non-painful procedures, which require a
relatively high level of brain awakeness, as this drug does not
produce complete anesthesia and has poor analgesic properties.
Furthermore, the only route for α-chloralose anesthesia is
through intravenous (IV) administration, which can render
the experiment more challenging than with isoflurane.
3 Methods
From a methodological perspective, there are two main types of
heteronuclear in vivo MRS studies: experiments that require
administration of exogenous tracers to increase the abundance of
the isotope investigated (like 13C MRS) or studies that do not need
it (like in 31P MRS). Naturally, studies involving infusion of labeled
molecules are methodologically more complex, because they
require the preparation, administration and maintenance of the
solution infused. More specifically, the experimental setup for a
typical 13C in vivo MRS study can be divided into four main
procedures, including: (1) preparation of the labeled solution,
(2) animal setup, (3) MRS preparation and acquisition, and
(4) administration of the labeled solution. A detailed description
of each step is given in the following paragraphs. Note that for





In vivo heteronuclear MRS experiments involve the utilization of
two labeled solutions with different labeling concentration. Initi-
ally, a solution at a very high enrichment, ideally 99% enriched
substrate (in labeled glucose 13C MRS this means 99% content of
13C and 1% content of 12C in the glucose solution) is given to the
animal during a short period of time. This increases rapidly the total
content of labeled glucose in the animal. Secondly, a solution at a
slightly lower enrichment—normally around 70%—is administered
at a steady rate during the rest of the experiment. This should keep
the targeted isotopic enrichment (IE) also at steady state. Remark-
ably, high IE’s (between 50 and 100%) are convenient to allow
reliable quantifications incorporated labeled carbons into glucose
and its metabolites. To prepare two solutions at a different frac-
tional enrichment, it is convenient to obtain first the 99% enriched
solution and then dilute it to get the 70%. With this aim, the 99%
labeled substrate should be dissolved into phosphate-buffered saline
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(PBS) at a proportion 20% w/v. Secondly, a part of this solution can
be used—we can fix 50 mL as an example—to obtain the 70%
enriched one. With this aim, an additional solution of non-labeled
glucose (also at 20% w/v) has to be prepared and mixed with the
50 mL of 99% enriched glucose. The specific amounts can be










) X ¼ 9:9
∗100
20∗0:7
¼ 70:71 mL½  ð2Þ
Y ¼ 70:71 50 ¼ 20:71 mL½  ð3Þ
where X represents the mL of 70% enriched glucose and Y the mL
of non-labeled glucose. These calculations take advantage of the
fact that the amount of 13C glucose in the 99% enriched solution
has to be the same as in the 70% enriched preparation [Eqs. 1 and
(2]. In our example, this means that by adding 20.71 mL of the
non-labeled glucose solution to the 50 mL 99% enriched we will
obtain 70.71 mL of 70% enriched solution at 200 g/L. Note that
depending on the complexity of the study two solutions might be
infused at the same time. For example, during [3-13C] lactate
infusion studies a non-labeled solution of glucose is given concom-
itantly to avoid production of 13C-enriched glucose from [3-13C]
lactate in peripheral tissues [22].
The line containing the substrate to infuse entails two separate
parts; a catheter and a long polyethylene tube connecting it with
the syringe containing the tracer solution. The catheter consists in a
cannula that is inserted into the animals’ vein plus a short plastic
tubing extension, filled with PBS. The length and thickness of the
line depends on the conditions of the laboratory and type of exper-
iment performed. The line and the syringe should be filled first with
the 70% enriched solution, while only a small amount of the 99%
enriched substrate is used. This amount, calculated depending on
the blood glucose levels and body weight (see Subheading 3.4), is
inserted in the tip of the line and will be the first part entering the
animal when infusion starts.
3.2 Animal Setup Before putting the animal inside the scanner, the following steps
should be followed:
1. Checking general status of the animal. Before starting an exper-
iment, the health of the animal needs to be checked and his
status reported. For 13C glucose infusion experiments, the
animal’s body weight and blood glucose levels should be
measured (see Note 1). Importantly, these values will be
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needed to calculate the amount and rate of the substrate infu-
sion (see Subheading 3.1).
2. Anesthesia. Animals can be anesthetized before insertion of the
cannula(s). To sedate the animals, volatile anesthetics like iso-
flurane are generally used, but other sedatives might be used,
depending on the type of study that is to be performed [25]. In
the case of isoflurane, it should be administrated at 3–4% for
induction (during approximately 3 min) and at 2% during
surgery, usually within a mixture of air (70%) and oxygen
(30%). If an anesthetic other than isoflurane is used—such as
α-chloralose or thiopental—a second catheter in a femoral vein
has to be placed for its infusion. In these cases, animals should
be intubated with an endotracheal catheter and ventilated with
a pressure-driven ventilator to ensure proper respiration.
3. Insertion of the cannula. It requires considerable expertise. To
perform the femoral vein catheterization, the inguinal region of
the anesthetized mouse has to be shaved. The femoral vessels
should be exposed after an inguinal cut parallel to abdominal
muscles. The subcutaneous branch of femoral vessels can be
eventually cauterized for fewer disturbances. With help of a
hemostat, the abdominal muscles must be hold above the
femoral vein, pulled and put under tension. This should expose
completely the femoral vein and compress it causing vasodila-
tation. Fibrous tissue covering the vein should be removed
using blunt forceps. Catheter will be inserted 2 mm in the
vein as distally as possible, while pulling the vein toward the
abdomen with help of forceps in order to stretch it sufficiently.
After letting go the forceps and losing tension on the hemostat,
the tube of the catheter (not the needle!) has to be pushed 1 cm
in the vein and the needle completely retracted. If the proce-
dure succeeded, blood from the vein should go up in the
catheter. A PBS-containing syringe is then connected to the
catheter from which injection of a few microliters in the vein
and withdrawal from the blood should indicate that the infu-
sion is working. The catheter has to be fixed on the vein and leg
using glue and the wound closed with silk suture. For more
safety, the catheter itself should be fixed on the leg with medical
tape. In experiments with rats, two catheters can be inserted:
one into a femoral vein to infuse the labeled solution and a
second into a femoral artery to extract blood and monitor
concentration of gases, glucose, lactate, and arterial blood
pressure. In studies using mice, however, because their total
blood volume is small, blood extraction during infusion pro-
tocols is not routinely performed. Alternatively to femoral vein
cannulation, which requires euthanasia of the animals at the
end of the experiment, animals can be cannulated at the level of
the lateral caudal vein (right or left). This is appropriate for
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longitudinal studies in which several in vivo heteronuclear MRS
measurements are intended. However, tail vein cannulations
are technically more challenging and several precautions need
to be considered (see Note 2 for extended explanation). In
both cases, it is important that temperature is maintained at
37 C during surgery.
4. Transfer to the holder. Pictures in Fig. 3 illustrate the elements
needed to keep animals in optimal conditions during the in vivo
MRS studies. Ideally, animals should be immobilized with
stereotaxic fixation, to minimize potential motion during the
MR session. Figure 3 shows examples of devices used to fix the
rat (right) and mice (left) heads.
5. Monitoring of the animal’s physiology. Body temperature should
be monitored during all MR procedures, since anesthesia is
known to decrease body temperature [25]. This is normally
done using a rectal temperature probe that should be inserted
Fig. 3 Animal immobilization in holders and supporting instrumentation. Left: The mouse head is fixed through
ear bars (in white) which are secured by small screwdrivers (in red). A small piece of acrylic glass covers the
animal’s mouth to avoid loss of anesthesia and prevent potential movements. An extra bar connects the
anesthetic tubing with the animal’s mouth. On the edge of this bar a small hole (in red) is used to place the
animal’s teeth. Blue water tubing is placed on top of the animal to maintain body temperature. The
thermometer cable can be seen coming out from the mouse body. The blue tubing on the right lateral of
the holder belongs to the respiration sensor, which is placed underneath of the animal’s belly. Right: The rat
head is fixed also through ear bars. A surface coil (double 1H in quadrature and single 31P) is place centered in
the animals’ head
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in the animals’ rectum using with some vaseline. Moreover, to
maintain body temperature in a physiological range—around
37 C—, circulating water tubes can be placed covering the
animal, as illustrated in Fig. 3 (left). It is also convenient to
monitor breathing rhythm. In this sense, concentration of
isoflurane can be adjusted in order to keep 70–100 bpm.
Finally, and to avoid corneal desiccation, a protective gel can
be applied on the animal’s eyes.
6. Positioning of the surface coil. We can carefully position the
surface coil into the animals’ head, as shown in Fig. 3 (right)
for the rat’s head (seeNote 3 for more details) and transfer the
holder into the magnet.
7. Connecting Infusion line. Finally, and before placing the animal
in the center of the scanner, we have to arrange and connect a
catheter that links the cannula in the animals’ vein with the
syringe containing the labeled solution.
3.3 MRS: Preparation
and Acquisition
Once the animal is in the magnet, the MRS preparation before
acquisition consists in: (1) positioning the holder in such a way
that the area to be investigated is in the center of the magnet;
(2) defining the voxel of interest (VOI), which normally involves
acquisition of high resolution anatomical images, and (3) adjusting
the first and second order gradient shims in the voxel [26], a
process that leads to an optimized resolution of the 1H spectra.
Note that for defining the VOI with a good anatomical reference it
might be convenient to perform T2-weighted acquisitions. Once
the VOI localization and shimming processes are performed, the
type of the study and the particular conditions of the experiment
will determine the type of sequences employed and the calibrations
performed. A description of the potential techniques to be used and
their respective adjustments is provided in the next subsections.
3.3.1 Localization
Techniques
To perform single voxel MRS, approaches that limit the excitation
in specific areas are used. Usually, localization is performed on the
1H magnetization for both direct and indirect detection methods,
but localization on the 13C is frequently possible [18]. Generally,
the specific conditions of the study will determine which localiza-
tion method is more suitable. Single voxel MRS can be accom-
plished by intersecting three different RF pulses, like in Point
Resolved Spectroscopy (PRESS) [27] and STimulated Echo Acqui-
sition (STEAM) [28] methodologies. Both techniques are based on
the spin echo (SE) sequence, with PRESS using a 90–180–180
scheme and STEAM employing three 90 pulses. In PRESS, the
90 pulse shifts the magnetization into the transverse plane, the
180 refocuses it only from one column and the last pulse refocuses
magnetization in the third dimension. Since the second pulse in
STEAM flips only half of the magnetization along z, only half of the
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possible signal intensity is acquired. Nevertheless, the larger band-
width of the 90 in STEAM for the same RF power implies less
errors due to chemical shift displacement has and can be used with
shorter echo times (TE) [29]. When short TE is used, homonuclear
J-coupling evolution among protons is minimized and additional
metabolites, such as glutamine, glutamate, γ-aminobutyrate, aspar-
tate, and myo-inositol can be detected with higher signal ampli-
tudes. Image Selected In vivo Spectroscopy (ISIS) [30] defines the
VOI using an add-subtract scheme. Briefly, the localization is per-
formed through multiple scans: in the first round of scans magneti-
zation is flipped into the transverse plane, and in the second
magnetization is inverted only in the VOI, and then flipped to
the opposite side of the transverse plane. The resulting signal is
subtracted, remaining only signal coming from the VOI. Since
localization is achieved through multiple scans, ISIS is prone to
be affected by movement, and is often employed together with
other localization techniques such as Outer Volume Suppression
(OVS). OVS approach defines the voxel by first exciting magneti-
zation outside the VOI and then dephasing it, while the magneti-
zation inside the VOI is not affected. Notably, SPin ECho full
Intensity Acquired Localized spectroscopy (SPECIAL) [31] is a
hybrid sequence that uses 1D ISIS localization with the first scan
(adiabatic 180 pulse) combined with a SE sequence (90–180), as
shown in Fig. 2a. It has some of the advantages of STEAM (used
with short TE) but it keeps the full signal. However, the
add-subtract scheme of the 1D ISIS can cause artifact movements
and it is often used with OVS. Note that for all localization
approaches the power needed to apply the 90 or 180 pulses
needs to be calibrated for each experimental condition.
3.3.2 Suppression
of the Water Signal
Suppression of the water signal can be achieved using CHEmical
Shift Selective pulses (CHESS) [32]. Values have to be calibrated
during each experimental session to obtain a minimum contribu-
tion of the water signal to the spectra. This can be achieved by using
a sequence with variable-power RF pulses with optimized relaxa-
tion delays, like (VAPOR) [33], and selecting the power that mini-
mizes the longitudinal magnetization of water.
3.3.3 Calibrations in 13C
Channel
In general, due to the low sensitivity of the 13C signal, calibrations
cannot be done in vivo and should be performed previously in vitro
in a phantom containing a known concentration of 13C labeled
molecules. Interestingly, using external bodies during calibration
and during the in vivo studies, such as formic acid spheres, is very
convenient (see Subheading 2).
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3.3.4 Decoupling
Schemes
Heteronuclear coupling between the X-nucleus and the 1H is rela-
tively large, and decoupling schemes [18] need to be implemented
to avoid splitting of the signal in several lines. 1H (or 13C) decou-
pling is usually done by applying a RF field (B2) at the Larmor
frequency of 1H (or 13C) [13], which can result in increased RF
power deposition and cause excessive heating in the tissue. In this
sense, it is useful to optimize decoupling power to the minimum.
The value should correspond to the minimum power that elimi-
nates most if not all effects of heteronuclear coupling signal.
3.3.5 13C Editing Block For 1H-[13C] methods, Adiabatic Full Passage (AFP) pulses in the
13C channel should be also calibrated previously in a phantom
containing a known concentration of 13C labeled molecules. Opti-
mized power should invert the total 1H-[13C] signal. Figure 2b
shows an example of a non-inverted, not-decoupled spectra of
labeled acetate (top), and inverted not-decoupled spectra of labeled
acetate (middle) after the application of the AFP pulse in the 13C
channel. The use of an external reference allows detecting potential
variations on the inversion performance of AFP pulses (see Sub-
heading 2).
3.4 Tracer Infusion Infusing a tracer inevitably increases the content of the substance in
particular. Because of the non-toxicity of the tracers used and the
intrinsic low sensitivity of heteronuclear MRS, the label is normally
administered in high quantities, with enrichments ranging between
50 and 100% [34]. Typically, the targeted final IE at steady state is
around 70%, and the infusion process is divided in two parts:
(1) administration of a bolus of labeled substrate (99% enriched)
during a short period of time at an exponential rate and (2) infusion
at a constant rate of 70% enriched solution that keeps the IE at
steady state during the rest of the experiment. Several factors such
as the volume of the glucose bolus infused, rates and time constant
of its administration need to be calculated beforehand. The next
sections explain in detail these calculations.
3.4.1 Glucose Plasma
Levels (Glcfinal)
The amount of 13C glucose in blood at the steady state of IE
(Glcfinal) should be equal to the sum of
13C glucose in blood at
initial basal levels (Glcbasal), enriched with natural abundance of
1.1%, and the administration of the 99% enriched bolus. This
relationship is expressed in Eqs. (4) and (5).
Glcfinal
∗IR ¼ Glcbasal∗ 1:1
100
þ Glcfinal Glcbasalð Þ∗ 99
100
ð4Þ
With IE ¼ 70%
Glcfinal ¼ Glcbasal∗ 1:1 99
70 99 ð5Þ





1 70ð Þ ) Glcfinal ¼
1
1 IRð ÞGlcbasal ð6Þ
With IE ¼ 70%
Glcfinal ¼ 3:33∗Glcbasal ð7Þ
This means that considering Eq. 7 final glucose values can be
calculated depending on the targeted IE. If physiological values are
to be maintained initial values of blood glucose should be low.
3.4.2 Glucose Bolus
Volume
Taking into account that the percentage of extracellular fluid in
rodents is around 20% of total body weight [35], and using Eq. 7 to
calculate the difference between basal and final glucose concentra-
tion, we can estimate that the total glucose bolus administrated in
g/kg of animal is 0.0047 * Glcbasal, as expressed in Eq. 8.
Total glc bolus g=kg½  ¼ 0:2∗ Glcfinal Glcbasalð Þ
¼ 0:0047∗Glcbasal ð8Þ
As an example, and to proceed with calculations, we will con-
sider a basal glucose level of 90 mg/dL—typical value mice after
overnight fasting in mice. We obtain a total bolus of 0.423 g/kg.
To transform expression 8 into volume values, we will consider an
estimated glucose disposal rate (eGDR) of 33.2 mg/kg/min [36],
duration of the bolus of 5 min, and a glucose solution of 200 g/L.
The total volume can be calculated as shown in Eq. 9 which
corresponds to 2.94 mL/kg of animal in our example.















The glucose bolus is habitually administered during 5 min follow-
ing an exponential decay. To calculate the time constant of the
decay (k), we can use the system of equations expressed in
Eqs. 10 and 11.
V t ¼ 0ð Þ ¼ V 0 ¼ 0:45  Total glc bolus ð10Þ
V t ¼ 5ð Þ ¼ V 0  e5k ¼ inf :rate ð11Þ
In Eq. 10 we express the assumption that the 45% of the total
bolus is infused in the first minute, while Eq. 11 states the fact that
in the last minute of the bolus the amount administered equals the
amount calculated with the constant infusion rate of glucose
administration (inf. rate) (see Subheading 3.4.4 for calculations),
both in 1 min.
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3.4.4 Infusion Rate After the administration of the glucose bolus, 70% enriched [1,
6-13C] glucose is infused at a rate equivalent to the eGDR,
33.2 mg/kg/min. If we are using a glucose solution of 200 g/L,
this infusion rate can be also expressed as 9.96 mL/kg/h. Ideally,
to keep the IE at a steady state, this value might need to be adjusted
based depending on concomitantly measured plasma glucose con-
centrations; if plasma glucose levels decrease infusion rate should be
increased by the same percentage, and if plasma glucose levels
increase the speed of administration of the glucose solution should
be decreased. In rats, these concomitant measurements can be
easily done by analyzing the sample extracts of the femoral artery,
which are normally performed every 15–30 min. In mice, however,
blood extractions are not performed routinely and alternative ways
of warranting IE stability are needed. In this respect, there are
basically two ways of checking this constancy of IE. The first one
consists in taking out the holder from center of the magnet and
removing a small drop of blood from the tip of the tail, with the
counterpart of having to reposition the animal in the exact same
place afterwards. Finally, values can also be checked using the brain
glucose and/or lactate FE calculations from MRS measurements.
4 Notes
1. Glucose measurements. In experiments with labeled glucose
infusions it is critical to measure the blood glucose levels in
several time points. Indeed, glucose values are used to calculate
the amount of 99% enriched substrate given. Interestingly, it is
important to know that the use of some anesthetics, like iso-
flurane, tend to increase glucose concentration in blood, which
is especially true after using high dosages like during induction.
Thus, before starting infusion it is useful—particularly in
experiments with mice, where blood extractions cannot be
performed once the animal is inside the scanner—to measure
blood glucose at the following time points: before induction
(1), after induction (2) and (3) in the holder before entering
the magnet. Ideally, values in (3) should be similar than values
in (1), indicating that a sort of stability is reached. If it is the
case, and the time between putting the mouse inside the scan-
ner and starting infusion is not too long, the value in (3) can be
used to calculate the 99% bolus volume. Otherwise it is recom-
mended to perform a fourth measurement right before starting
infusion, removing the mouse form the scanner, with the
counterpart of having to position two times the mouse in the
magnet. In experiment with bigger animals this can be solved
by having a line to extract blood from the femoral artery.
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2. Tail vein vs. femoral vein. Tail vein cannulations are more fragile
than cannulations in femoral vein, but they are mandatory to
perform longitudinal studies with measurements at different
time points. The protocol for cauterization is similar than for
femoral vein, but its smaller size and localization makes it easier
for the needle to accidentally come out. This means that animal
manipulation has to be done with special care. Also, the smaller
size of the vein makes tail vein cannulation more prone to be
closed and blocked (partially or completely) the entrance of
infusion. To avoid this, two precautions should be taken: keep
the tail at warm temperatures while animal preparation and
check its circulation by infusing of small amounts of PBS during
animal preparation. In fact, once the animal is in the scanner it is
always convenient to start infusion only with PBS to keep the
line opened. Finally, it is important to take special care of the tail
at the end of each MRS session. Sometimes small injuries caused
by cannulations can end up with damages in the tail that prevent
its usage for the following time points.
3. Careful positioning of the surface coil. Being poor sensitivity one
of the main issues in heteronuclear MRS, the position of the
coil should be optimized to increase SNR in the area of interest.
With this aim, it is convenient to perform pilot studies to
determine which position enhances mostly the signal in this
area. Besides, it is recommended to implement periodically
additional tests in phantoms that make sure performance of
the coil is not affected.
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